Antiviral adaptive immune responses, mediated by effector Ag-specific CD4 + and CD8 + T cells, are required for the regulation of JE progression by controlling and clearing JEV in extraneural tissues and the CNS [13, 14, 52]. The gene discussed is CD8A; the disease is Japanese encephalitis.